Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
Market highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
ASX Health Stocks: Mesoblast’s Q3 revenues, Osprey restructures business to reduce debt
News
ASX Large Caps: Tech index climbs 4pc amid hopes US inflation may have peaked
Health & Biotech
ASX Health Stocks: Invion demonstrates efficacy, Biotron gets feedback from the FDA
Experts
ScoPo’s Powerplays: Green shoots appear among smaller ASX health stocks
News
ASX Large Caps: Blue chips on a roll as investors shrug off recession fears
Experts
ScoPo’s Powerplays: Which ASX health stocks are winners from the Federal Budget?
News
Closing Bell: Tech stocks, consumer names lead as small caps close higher
News
ASX Large Caps: Bull run continues as ASX 200 notches six gains in a row
Health & Biotech
ASX Health Stocks: CBD gel could become cornerstone therapy for hand arthritis, says Avecho
Health & Biotech
ASX Health Stocks: Telix takes major leap forward on Phase 3 ZIRCON study of kidney cancer
Health & Biotech
ASX Health Stocks: Healthcare index surges as CSL revels in blood plasma boom
Health & Biotech
ASX Health Stocks: Resonance gets green light in US; Althea buys German cannabis company
Experts
SocPo’s Powerplays: A few healthcare gems among the carnage
News
Here are the top ASX large cap movers for Monday
Health & Biotech
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs
Experts
